Literature DB >> 20660815

Prasugrel.

Stephen D Wiviott1, Elliott M Antman, Eugene Braunwald.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20660815     DOI： 10.1161/CIRCULATIONAHA.109.921502

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Stroke Genetics Update: 2011.

Authors:  John W Cole; James F Meschia
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

Review 2.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

3.  Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel versus Clopidogrel.

Authors:  E J Ha; W S Cho; J E Kim; Y D Cho; H H Choi; T Kim; J S Bang; G Hwang; O K Kwon; C W Oh; M H Han; H S Kang
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-07       Impact factor: 3.825

Review 4.  Antiplatelet Therapy in Acute Coronary Syndrome.

Authors:  Kerry Layne; Albert Ferro
Journal:  Eur Cardiol       Date:  2017-08

Review 5.  New information on the genetics of stroke.

Authors:  James F Meschia
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

6.  [New antiplatelet agents and the question of dual antiplatelet therapy].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

7.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

8.  Contributions of intestine and plasma to the presystemic bioconversion of vicagrel, an acetate of clopidogrel.

Authors:  Zhixia Qiu; Ning Li; Ling Song; Yang Lu; Jing Jing; Harendra S Parekha; Wenchao Gao; Fengjie Tian; Xin Wang; Shuangxia Ren; Xijing Chen
Journal:  Pharm Res       Date:  2013-09-14       Impact factor: 4.200

Review 9.  TRITON and beyond: new insights into the profile of prasugrel.

Authors:  Joseph A Jakubowski; Jeffrey S Riesmeyer; Sandra L Close; Amy G Leishman; David Erlinge
Journal:  Cardiovasc Ther       Date:  2011-02-17       Impact factor: 3.023

Review 10.  Facilitated/pharmaco-invasive approaches in STEMI.

Authors:  Davide Capodanno; George Dangas
Journal:  Curr Cardiol Rev       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.